AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9638854
Drug: Low-dose ATG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ATG (total dose 484 +/- 110 mg, 0.75 mg/kg per day)
Trial: 9638854
Drug: Low-dose OKT3
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose OKT3 (total dose 32 +/- 4 mg, 0.05 mg/kg per day)
Trial: 9638854
Drug: Low-dose OKT3
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose OKT3
Trial: 28162127
Drug: Monthly food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly food voucher of $US 40
Trial: 28162127
Drug: Monthly food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly food voucher of $US 40 plus training on health and nutrition
Trial: 25119510
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline injection into the long posterior sacroiliac ligament
Trial: 25119510
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline injection on the contralateral side
Trial: 22085683
Drug: Acupuncture as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture as an adjunct to pharmacotherapy
Trial: 9715427
Drug: Amitriptyline 25
RxNorm normalized name: amitriptyline 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 25 mg for the first week, 50 mg for the second week, and 75 mg nightly thereafter for 12 weeks
Trial: 2737169
Drug: Sip-feed supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sip-feed supplements
Trial: 2737169
Drug: Non-compliant patients
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-compliant patients (who failed to receive supplements)
Trial: 22894624
Drug: AMR101 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMR101 4 g/day
Trial: 22894624
Drug: AMR101 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMR101 2 g/day
Trial: 21683321
Drug: AMR101 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMR101 4 g/day (baseline TG >750 mg/dl)
Trial: 21683321
Drug: AMR101 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMR101 2 g/day (baseline TG >750 mg/dl)
Trial: 19390542
Drug: losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan 50 mg/HCTZ 12.5 mg (titrated to losartan 100 mg/HCTZ 12.5 mg at 4 weeks and losartan 100 mg/HCTZ 25 mg at 8 weeks)
Trial: 19390542
Drug: losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan 50 mg/HCTZ 12.5 mg
Trial: 19390542
Drug: losartan/HCTZ combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: losartan/HCTZ combination therapy
Trial: 15572179
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 and 2 mg on two successive days)
Trial: 27600795
Drug: Omacor® 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omacor® 4 g/day
Trial: 27600795
Drug: Omacor® 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omacor® 2 g/day
Trial: 26068602
Drug: UFT/LV (tegafur-uracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFT/LV (tegafur-uracil with leucovorin) administered at 300 mg/m²/day with 75 mg/day for 5 courses (5 weeks each)
Trial: 21804100
Drug: Two fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two fixed-dose combination tablets (ibuprofen 400 mg/paracetamol 1000 mg)
Trial: 21804100
Drug: One fixed-dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One fixed-dose combination tablet (ibuprofen 200 mg/paracetamol 500 mg)
Trial: 21804100
Drug: One combination
RxNorm normalized name: urine glucose-acetone combination test strips
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One combination tablet (ibuprofen 200 mg/paracetamol 500 mg)
Trial: 21804100
Drug: Two combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two combination tablets (ibuprofen 400 mg/paracetamol 1000 mg)
Trial: 12962764
Drug: Dual-drug therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-drug therapy (tacrolimus and corticosteroids)
Trial: 12962764
Drug: Triple-drug therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug therapy (tacrolimus, azathioprine, and corticosteroids)
Trial: 8621832
Drug: Combination UVB/UVA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination UVB/UVA phototherapy
Trial: 6530538
Drug: Low sodium
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sodium diet (50 mmol daily)
Trial: 6530538
Drug: High sodium
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High sodium diet (300 mmol daily)
Trial: 6530538
Drug: Intravenous frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous frusemide administration
Trial: 30659039
Drug: Daily intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intake of refined wheat bread enriched with 6 g of wheat germ
Trial: 25205802
Drug: Pooled cohort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pooled cohort (TAVR, n=220; standard therapy, n=229)
Trial: 22828688
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bupivacaine 0.5% plus 5 μg dexmedetomidine (dexmedetomidine group)
Trial: 22828688
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bupivacaine 0.5% plus 5 μg dexmedetomidine and 25 μg fentanyl (dexmedetomidine= group)
Trial: 22828688
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg bupivacaine 0.5% (control group)
Trial: 22987572
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg rosuvastatin
Trial: 9651560
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg pravastatin
Trial: 12486428
Drug: rosuvastatin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin (5 mg and 10 mg)
Trial: 8133086
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with zidovudine and didanosine (ddI)
Trial: 241115
Drug: Sucrose-containing iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose-containing iron medicines
Trial: 241115
Drug: 50% aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50% aqueous sucrose solution
Trial: 241115
Drug: Iron medicines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron medicines with sorbitol
Trial: 27918724
Drug: telotristat ethyl
RxNorm normalized name: Telotristat ethyl
DrugBank: Telotristat ethyl (DB12095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: telotristat ethyl 250 mg
Trial: 27918724
Drug: telotristat ethyl
RxNorm normalized name: Telotristat ethyl
DrugBank: Telotristat ethyl (DB12095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: telotristat ethyl 500 mg
Trial: 27918724
Drug: telotristat ethyl
RxNorm normalized name: Telotristat ethyl
DrugBank: Telotristat ethyl (DB12095)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: telotristat ethyl 250 mg and 500 mg
Trial: 22074836
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, only observation)
Trial: 15633321
Drug: 3% potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% potassium oxalate gel
Trial: 10728365
Drug: 2 I.U.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 I.U. of recombinant human growth hormone (GH) for 3 months
Trial: 8957033
Drug: Conventional antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antihypertensive drugs (n = 35)
Trial: 3575131
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg i.m. of Phytonadione (Konakion, Roche) administered on the initial day of GFD
Trial: 3575131
Drug: No vitamin
RxNorm normalized name: Vitamin B12 NOS
DrugBank: Cyanocobalamin (DB00115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No vitamin K administration (Control group)
Trial: 26733351
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus (one ComProbi capsule containing L. rhamnosus a day)
Trial: 26733351
Drug: Placebo (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (one capsule of placebo a day)
Trial: 25454870
Drug: Vaccine, IL-2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine, IL-2, GM-CSF and rhGH (n=3)
Trial: 25454870
Drug: Vaccine alone
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine alone (n=4)
Trial: 19201650
Drug: Erlotinib (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib (150 mg daily) and bevacizumab (15 mg/kg every 3 weeks)
Trial: 11269613
Drug: Beef protein
RxNorm normalized name: Beef
DrugBank: Beef (DB10509)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beef protein (43 g for women and 50 g for men daily)
Trial: 9464712
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein isolate (60 g daily containing 40 g of isolated soy protein)
Trial: 9464712
Drug: Placebo (casein,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (casein, 60 g daily)
Trial: 794897
Drug: Amitriptyline (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (150 mg daily)
Trial: 794897
Drug: L-tryptophan (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-tryptophan (8 g daily)
Trial: 27539689
Drug: Single antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single antiplatelet therapy
Trial: 30537411
Drug: Exercise dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise dose (kilocalories per session)
Trial: 23558043
Drug: ivabradine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivabradine (5 mg twice daily)
Trial: 23558043
Drug: ranolazine (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranolazine (375 mg twice daily)
Trial: 22010346
Drug: Tangshen Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tangshen Formula + Conventional western medicine
Trial: 17557758
Drug: Alendronate (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (10 mg)
Trial: 14999637
Drug: Megestrol acetate
RxNorm normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Megestrol acetate (800 mg every day)
Trial: 14999637
Drug: Oxandrolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxandrolone (10 mg twice per day)
Trial: 7985255
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg terbutaline
Trial: 7985255
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg terbutaline
Trial: 7985255
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg terbutaline
Trial: 8491302
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of terbutaline (2, 4, 6 mg)
Trial: 6366126
Drug: Any oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any oral intestine decontamination regimen
Trial: 27005498
Drug: Low lactose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low lactose milk powder feeding in treatment group (64 cases)
Trial: 27005498
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (rehydration, correction of acidosis, oral smecta, intestinal probiotics) in control group (60 cases)
Trial: 27005498
Drug: Low lactose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low lactose milk powder feeding in treatment group
Trial: 27005498
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment in control group
Trial: 20073409
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of daily OxyContin
Trial: 20073409
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg of daily OxyContin
Trial: 20073409
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg of daily OxyContin
Trial: 16962929
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/day for 14 days
Trial: 8548465
Drug: Ioxaglate (Hexabrix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ioxaglate (Hexabrix 320; 40 to 240 mL, mean 141 mL)
Trial: 8548465
Drug: Ioversol (Optiray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ioversol (Optiray 320; 20 to 180 mL, mean 87 mL)
Trial: 1808526
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injections with Depo‐Medrol or Polcortolon plus bupivacaine
Trial: 1808526
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injections with Polcortolon plus bupivacaine
Trial: 31778446
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg/day for 16 weeks
Trial: 31778446
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral isotretinoin 0.3-0.4 mg/kg for 16 weeks
Trial: 30327236
Drug: Sequential or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential or radiotherapy alone
Trial: 28807086
Drug: Oral steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroids followed by intranasal steroids (Group A)
Trial: 28807086
Drug: Oral steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroids alone (Group B)
Trial: 24229669
Drug: Basal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal insulin therapy (including a single injection of basal insulin and basal insulin plus preprandial insulin)
Trial: 24229669
Drug: Premixed insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premixed insulin therapy
Trial: 20642328
Drug: Support group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Support group participation (12 monthly support group meetings)
Trial: 19542400
Drug: Low-dose unenhanced
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose unenhanced CT
Trial: 19542400
Drug: Standard-dose i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose i.v. contrast-enhanced CT
Trial: 16942934
Drug: Subjects with
RxNorm normalized name: Ex vivo, lentiviral vector (LV)-mediated, genetically modified autologous cell therapy intended for the stable provision of functional human iduronate-2-sulfatase (IDS) enzyme to subjects with Hunter syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subjects with the most common genotype combination of SNPs (‐604G/A, ‐501A/C, Leu72Met, Gln90Leu)
Trial: 15501741
Drug: Valium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valium (0.1 mg/kg)
Trial: 15501741
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (50 mg/kg)
Trial: 15501741
Drug: Valium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valium (0.1 mg/kg) and Magnesium sulfate (50 mg/kg)
Trial: 9366103
Drug: Lisinopril 20
RxNorm normalized name: lisinopril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 20 mg/hydrochlorothiazide 12.5 mg
Trial: 9366103
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg/hydrochlorothiazide 25 mg
Trial: 2931040
Drug: Procaterol metered-dose
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol metered-dose inhaler
Trial: 18929702
Drug: Thienopyridine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thienopyridine therapy continued beyond 1 year
Trial: 18929702
Drug: Thienopyridine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thienopyridine therapy discontinued after 1 year
Trial: 11431603
Drug: Nasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal insulin administration (gelified form)
Trial: 11431603
Drug: Subcutaneous regular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous regular insulin injections
Trial: 8027276
Drug: Nafarelin acetate
RxNorm normalized name: Nafarelin Acetate
DrugBank: Nafarelin (DB00666)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nafarelin acetate (nasal spray)
Trial: 8027276
Drug: Buserelin acetate
RxNorm normalized name: buserelin acetate
DrugBank: Buserelin (DB06719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buserelin acetate (nasal spray)
Trial: 2513939
Drug: Three days'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three days' treatment with co-trimoxazole 960 mg twice a day
Trial: 2513939
Drug: Seven days'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seven days' treatment with co-trimoxazole 960 mg twice a day
Trial: 31705450
Drug: Boiled dill
RxNorm normalized name: Dill
DrugBank: Dill (DB10673)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boiled dill seed (10 g boiled in 100 mL for 10 min, given orally at the beginning of active phase)
Trial: 31705450
Drug: Oxytocin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (10 IU in 1000 mL of Ringer solution)
Trial: 27320685
Drug: PDL-only treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDL-only treatment
Trial: 27320685
Drug: rapamycin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rapamycin monotherapy
Trial: 25399948
Drug: Shortened (46
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shortened (46 weeks), intensified therapy
Trial: 23221935
Drug: 1500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg/day of encapsulated WGOE
Trial: 18649754
Drug: Cernilton 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cernilton 750 mg, twice a day for 4 years
Trial: 18649754
Drug: Cernilton 375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cernilton 375 mg, twice a day for 4 years
Trial: 18649754
Drug: Cernilton 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cernilton 750 mg
Trial: 18649754
Drug: Cernilton 375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cernilton 375 mg
Trial: 17050212
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs (baseline)
Trial: 10978253
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (182 mg of RRR‐alpha‐tocopherol acetate per day)
Trial: 10978253
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg of slow release ascorbate per day)
Trial: 10978253
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of vitamin E and C
Trial: 1346413
Drug: Clindamycin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin (300 mg twice daily)
Trial: 6593316
Drug: 100 rad
RxNorm normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 rad X 18 cranial radiation therapy
Trial: 6593316
Drug: 180 rad
RxNorm normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 180 rad X 10 cranial radiation therapy
Trial: 30885073
Drug: Ertapenem (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertapenem (one dose)
Trial: 30885073
Drug: Ampicillin, gentamicin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin, gentamicin, and clindamycin (AGC-1, one-time intravenous dose)
Trial: 20664838
Drug: 0.3 mg/mL
RxNorm normalized name: menthol 0.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/mL recombinant human platelet‐derived growth factor (rhPDGF‐BB) with beta‐tricalcium phosphate (b‐TCP)
Trial: 20664838
Drug: 0.3 mg/mL
RxNorm normalized name: menthol 0.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/mL recombinant human platelet‐derived growth factor (rhPDGF‐BB) with collagen containing anorganic deproteinized bovine bone (xenograft)
Trial: 20664838
Drug: 0.3 mg/mL
RxNorm normalized name: menthol 0.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/mL recombinant human platelet‐derived growth factor (rhPDGF‐BB) with either b‐TCP or xenograft